Immune Checkpoint Inhibitors

Immune Checkpoint Inhibitors

Sponsored by

Cancer cells often evade an immune system attack by co-opting immune checkpoint proteins like PD1 and PD-L1. The details behind how immune checkpoint inhibitors are being developed to expose and correct this covert process are covered here.

Editorial Content